# Identifai-Genetics

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/identifai-genetics

- Industry: Biotechnology
- Headquarters: Tel Aviv, Israel
- Website: www.identifai-genetics.com
- Total disclosed funding: $3.3M
- Latest round: Seed (Apr 18, 2023)
- Investors on record: 1

## About

Based in Israel and founded in 2021, idefntifAI LTD provides a clinical solution for early, non-invasive, and comprehensive prenatal genetic screening. The company was co-founded by Mr. Yossi Bornstein, Prof. Noam Shomron (CSO), Dr. Tom Rabinowitz (CTO), and Dr. Amir Beker (CEO). In April 2023 the firm raised USD 3.3M in post-seed funding led by eHealth Ventures, digital health VC funds, and Dr. Ron Sabar, founder and CMO of Sabar Health.

The company offers an early and comprehensive prenatal screening test for genetic syndromes through taking a blood test from the mother during the first trimester of the pregnancy. The company uses data science algorithms to provide a high-resolution picture of the fetus’s health at the early stage of the pregnancy from point mutations to chromosomal anomalies.

## Funding rounds

- Seed, Apr 18, 2023, $3.3M — eHealth Ventures

## Investors

- eHealth Ventures (https://capitalatlas.ai/funds/ehealth-ventures) — Seed